1. Catalog
  2. CME ONDemand: 2024 Advanced Foot and Ankle Course
CME ONDemand: 2024 Advanced Foot and Ankle Course
Image For Activity Cover
Availability
On-Demand
Expires on 11/18/2027
Cost
Member: $350.00
Non-Member: $550.00
Credit Offered
11.75 CME (MD) Credits
11.75 MOC Points
11.75 CME (PA/NP/RN) Credits
11.75 CEU (AT) Credits
11.75 CE (PT) Credits
11.75 CME (DPM) Credits
  • Course Overview
  • Agenda
  • Faculty & Planner Disclosures
  • CME Overview
  • CME Overview

What do you do when a surgery does not work? How do you tackle complex problems in young and athletic patients? When and who do you call for help? The AOFAS Advanced Foot & Ankle Virtual Course is a comprehensive course covering a range of topics that will assist every surgeon in treating their most difficult cases.

 

Upon completion of this course, learners should be able to:

  • Compare and contrast approaches for treating routine and complex foot and ankle deformities and conditions

  • Describe patient selection and treatment strategies for revision procedures

  • Outline the ways to identify and manage complications

  • Determine and apply strategies to improve patient outcomes


The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AOFAS designates this enduring materials activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery's Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.
For more information on AOFAS accreditation and educational policies, visit the Program Overview page.



Symposium 1 – Adolescent and Young Adult Problems
Moderator: Jacob R. Zide, MD

Adolescent Bunion
Colin May, MD

Tarsal Coalitions and Rigid Flatfoot
Maryse Bouchard, MD, MSc

The Young Cavovarus Deformity
Anthony I. Riccio, MD

Residual/Uncorrected Club Foot in the Young Adult
Jacob R. Zide, MD

Cases and Discussion

Symposium 2 – The Complicated Athlete
Moderator: Christopher P. Miller, MD, MHS

Considerations for Handling the Professional or Collegiate Athlete
Martin J. O'Malley, MD

The Aging Athlete
Cristian A. Ortiz, MD

Deformity: When Does It Need to Be Addressed?
Mark C. Drakos, MD

Sky High Expectations: Patient and "Team"
Robert B. Anderson, MD

Cases and Discussion

 

Symposium 3 – Managing Complications of Forefoot Surgery
Moderator: Elizabeth Cody, MD

Bunion Recurrence
Scott J. Ellis, MD

Hallux Varus: When to Reconstruct vs Fuse
Anthony Ndu, MD

MIS Complications
Rebecca A. Cerrato, MD

Lesser Toes
Elizabeth Cody, MD

Cases and Discussion

Support for this symposium is provided by an educational grant from Medline UNITE Foot & Ankle.

Symposium 4 – Malunions & Malalignment: Part 1
Moderator: Christopher P. Miller, MD, MHS

Calcaneal Malunion
John Y. Kwon, MD

Revision Ankle ORIF
Max P. Michalski, MD

Neuropathic Hindfoot/Ankle Trauma
Amgad M. Haleem, MD, PhD

Navicular Stress Fractures and Nonunions
Christopher P. Miller, MD, MHS

Cases and Discussion


Symposium 5 – Malunions and Malalignment: Part 2
Moderator: Jacob R. Zide, MD

Lapidus Complications
Christina Stukenborg-Colsman, MD

Revision Peroneal and Ankle Ligament Reconstruction
James W. Brodsky, MD

Failed Flatfoot
Casey J. Humbyrd, MD, MBE

Ankle Malalignment
Anish R. Kadakia, MD

Cases and Discussion

 

Symposium 6 – Complications of Total Ankle Replacement
Moderator: Elizabeth Cody, MD

Why Does My Ankle Still Hurt?: The Painful Total Ankle Replacement
Lew C. Schon, MD

Managing the Stiff TAR
Constantine A. Demetracopoulos, MD

Intra-operative Problems
Karl M. Schweitzer Jr., MD

Fireside Chat: What Can TAR Learn from TKA?
Elizabeth B. Gausden, MD, MPH

Cases and Discussion

 

Symposium 7 – Nonunions and Bone Loss
Moderator: Jacob R. Zide, MD

Talar AVN
Amanda J. Fantry, MD

Primary Fusion for Ankle/Hindfoot Trauma
Todd A. Irwin, MD

Managing Large Tibial/Talar Bone Defects
Brian M. Weatherford, MD

Biologics for Fusion
Jason T. Bariteau, MD

Cases and Discussion

Symposium 8 – Calling for Help
Moderator: Christopher P. Miller, MD, MHS

Opioid Free Pain Management
A. Holly Johnson, MD

What Does Foot & Ankle Need to Know from PRS?
Sammy Dowlatshahi, MD

Psychological Pain
Whitney Herge, PhD

Vascular Surgery
Mark C. Wyers, MD

Cases and Discussion

Christopher P. Miller, MD, MHS

  • Enovis: Consultant
  • Arthrex, Inc.: Consultant

Jacob R. Zide, MD

  • Orthofix Medical, Inc.: Consultant

Elizabeth A. Cody, MD

  • HS2 LLC: Ownership
  • HSS ASC Development Network LLC: Ownership
  • Johnson & Johnson: Consultant
  • Stryker: Consultant

Robert B. Anderson, MD

  • Artelon: Consultant
  • DJO: Consultant
  • Arthrex, Inc.: Consultant
  • Stryker: Consultant
  • Intellectual Property: Other Intellectual Property

Jason T. Bariteau, MD

  • stridelink: Stock Options
  • restor3d, inc.: Stock
  • Seaspine Orthopedics Corporation: Consultant
  • DJO: Consultant
  • Intellectual Property: Other Intellectual Property

Maryse Bouchard, MD, MSc

  • OrthoPediatrics Corp.: Consultant
  • OrthoFlexion: Stock (CEO, Unpaid)

James W. Brodsky, MD

  • Nothing to Disclose

Rebecca A. Cerrato, MD

  • Stryker: Consultant
  • Acumed LLC: Resident Educational Speaker
  • Vilex LLC: Consultant
  • Intellectual Property: Other Intellectual Property

Constantine A. Demetracopoulos, MD

  • Artelon: Consultant
  • Arthrex: Consultant
  • Enovis: Consultant
  • HS2 LLC: Stock
  • In2Bones: Consultant; IP Royalties
  • Responsive Arthroscopy LLC: Consultant
  • restor3d, inc.: Consultant
  • RTI Surgical, Inc.: Consultant
  • Simulate Technologies: Consultant
  • Treace Medical Concepts, Inc.: Consultant
  • Exactech, Inc.: IP Royalties
  • Wolters Kluwer Health - Lippincott Williams & Wilkins: Publishing Royalties

Sammy Dowlatshahi, MD

  • Nothing to Disclose

Mark C. Drakos, MD

  • Intellectual Property: Other Intellectual Property

Scott J. Ellis, MD

  • Elsevier Publishing: Consultant
  • Springer: Consultant
  • Foot Innovate: Consultant
  • Curvebeam: Consultant
  • Stryker: Consultant
  • Vilex LLC: Consultant
  • Medartis: Consultant
  • Extremis Robotics: Consultant
  • Paragon 28: Consultant
  • Intellectual Property: Other Intellectual Property

Amanda J. Fantry, MD

  • Nothing to Disclose

Elizabeth B. Gausden, MD, MPH

  • DePuy Orthopaedics Inc.: Consultant
  • Stryker: Consultant

Amgad M. Haleem, MD, PhD

  • Vilex LLC: Consultant
  • Orthofix Medical, Inc.: Consultant
  • Stryker: Consultant

Whitney Herge, PhD

  • Nothing to Disclose

Casey J. Humbyrd, MD

  • Intellectual Property: Copyright

Todd A. Irwin, MD

  • Paragon 28: Consultant
  • Vilex LLC: Consultant
  • Marrow Access Technologies: Consultant
  • Medline Industries, Inc.: Consultant

A. Holly Johnson, MD

  • Altier Trauma: Stock
  • Carbon 22: Stock
  • Motio: Other Business Ownership
  • Forma Orthopaedics: Other Business Ownership
  • Treace Medical Concepts: Consultant; Other Intellectual Property
  • Novastep: Royalties

Anish R. Kadakia, MD

  • Arthrex, Inc.: Consultant
  • Intellectual Property: Other Intellectual Property

John Y. Kwon, MD

  • Paragon 28: Consultant
  • DJO: Consultant
  • restor3d, inc.: Consultant
  • Intellectual Property: Other Intellectual Property

Colin May, MD

  • OrthoPediatrics Corp.: Consultant

Max P. Michalski, MD

  • Extremity Medical: Consultant
  • Intellectual Property: Other Intellectual Property

Anthony Ndu, MD

  • Smith and Nephew: Consultant
  • Tyber Medical: Consultant
  • Johnson & Johnson: Consultant

Martin J. O'Malley, MD

  • Nothing to disclose

Cristian A. Ortiz, MD

  • Acumed: Consultant
  • DePuy Synthes: Consultant

Anthony I. Riccio, MD

  • OrthoPediatrics Corp.: Consultant

Lew C. Schon, MD

  • Zimmer Biomet: Consultant
  • Curvebeam AI: Stock
  • Intellectual Property: Patent

Karl M. Schweitzer Jr., MD

  • Stryker: Consultant
  • Ibex, Inc.: Consultant; Stock Options
  • Tayco Brace, Inc: Consultant; Stock Options
  • restor3d, inc.: Stock Options

Christina Stukenborg-Colsman, MD

  • Nothing to Disclose

Brian M. Weatherford, MD

  • Stryker: Consultant
  • DePuy Synthes: Consultant

Mark C. Wyers, MD

  • Nothing to Disclose

All relevant disclosures have been mitigated.
CMS:{CME}

Statement of Need

A need for this educational activity has been determined based on previous course evaluations and the AOFAS educational curriculum. The content of this course was based on current issues and topics provided by AOFAS membership and leadership. For more information on the AOFAS CME mission, visit aofas.org/education.


Accreditation

The American Orthopaedic Foot & Ankle Society (AOFAS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.


Disclaimer

The material presented in this continuing medical education activity has been made available by the American Orthopaedic Foot & Ankle Society (AOFAS) for educational purposes only. This material is not intended to represent the only, nor necessarily the best, methods or procedures appropriate for the medical situation discussed, but rather is intended to present an approach, view, statement, or opinion of the authors or presenters, which may be helpful or of interest to other practitioners. Methods, techniques, and procedures demonstrated and views and opinions expressed by speakers, presenters, and faculty are their own, and do not necessarily represent those of AOFAS, nor does presentation on the program represent or constitute endorsement or promotion by AOFAS. AOFAS expressly disclaims any warranties or guarantees, expressed or implied, and shall not be liable for damages of any kind in connection with the material, methods, information, techniques, opinions, or procedures expressed, presented, or demonstrated.


Disclosure of Conflict of Interest

Disclosure Statement
AOFAS mandates all instructors, planners, and other individuals in a position to control or influence the content of an educational activity to disclose all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All identified conflicts must be mitigated, and the education content vetted by the AOFAS for fair balance, scientific objectivity, and appropriateness. All disclosures will be provided in this final program distributed at the meeting to all program participants.

FDA Statement
Some drugs or medical devices demonstrated at this meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical devices he or she wishes to use in clinical practice. AOFAS policy provides that "off label" uses of a drug or medical device may be described in its CME activities so long as the "off label" use of the drug or medical device is also specifically disclosed (i.e., it must be disclosed that the FDA has not cleared the drug or device for the described purpose). Any drug or medical device is being used "off label" if the described use is not set forth on the products approval label.

Faculty/Planner Disclosure Declaration
As an Accreditation Council for Continuing Medical Education (ACCME) provider, AOFAS has the obligation to ensure the delivery of education that is balanced and free of commercial bias. To achieve this, it is the policy of the AOFAS that all CME-related Board, committee members ("planners"), faculty, and appropriate staff disclose in writing to the learners all financial relationships that you have had in the past 24 months with ineligible companies. An "ineligible company" is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

In addition to faculty members, commentators from the floor are charged with verbally disclosing any interests immediately prior to speaking. All disclosures are provided in this final program distributed at the meeting to all program participants.

In accordance with AOFAS policy:
Faculty participation in this educational activity will be predicated upon timely submission and review of AOFAS disclosure. An individual who refuses to disclose relevant financial relationships will be disqualified from being a planning committee member, a teacher, or an author of CME, and cannot have control of, or responsibility for, the development, management, presentation, or evaluation of the CME activity. Non-compliance will result in a faculty member being stricken from the program.

An indication of the participant's disclosure appears after his or her name as well as the commercial company or institution that provided the support. AOFAS does not view the existence of these disclosed interests or commitments as necessarily implying bias or decreasing the value of the author's participation in this activity. In addition to ensuring that presentations be free of bias, faculty members are required to ensure that all material presented and discussed will be based on best-available evidence.

American Orthopaedic Foot & Ankle Society®
1515 E. Woodfield Road, Suite 850, Schaumburg, IL 60173
Phone: +1-847-698-4654
Copyright© 2024 All Rights Reserved
Powered By